Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 71335-2764

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 71335-2764). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zolpidem Tartrate (39503a0f Bbf2 4bb4 Ab5d 118d2e3b5bbf 01)

Chemical structure diagram showing the molecular structure of Zolpidem Tartrate, featuring the indole and phenyl groups with tartrate moiety displayed on the right side as part of the salt form.*

FDA Label Image

Im-2 (39503a0f Bbf2 4bb4 Ab5d 118d2e3b5bbf 02)

A line graph comparing zolpidem plasma concentrations (ng/mL) over time (hours) for 12.5 mg zolpidem tartrate extended-release tablets and 10 mg zolpidem tartrate immediate-release tablets. The graph shows plasma levels rising rapidly, peaking between 1 and 2 hours, then declining over 8 hours with the extended-release maintaining higher concentrations after 2 hours compared to immediate-release.*

FDA Label Image

Image (39503a0f Bbf2 4bb4 Ab5d 118d2e3b5bbf 304 1)

ZOLPIDEM TARTRATE 6.25 mg extended release oral tablets packaging from Bryant Ranch Prepack. The image shows a blister card containing twelve round tablets arranged in a 3x4 grid with individual foil seals on each tablet.*

FDA Label Image

Image (39503a0f Bbf2 4bb4 Ab5d 118d2e3b5bbf 334 1)

The image shows a blister pack containing 10 extended-release tablets of Zolpidem Tartrate, 6.25 mg. The tablets are round and white, arranged in two columns of five each. The packaging is plain with no visible text or branding on the front side of the blister pack, consistent with prescription medication tablets distributed by Bryant Ranch Prepack.*

FDA Label Image

Label (Lbl713352764)

Label for Zolpidem Tartrate Extended-Release Tablets USP 6.25 mg, containing 100 tablets for oral use. The product is relabeled by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Lupin Limited. The label includes dosage instructions, storage conditions, child safety warnings, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.